Ask in Claude
Ask in ChatGPT
16 episodes
Beyond Biotech - the podcast from Labiotech
by Labiotech · English
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. The host is Dylan Kissane.
Latest episodes
All episodes
Inside Arbor’s CNS pipeline and next-generation gene editing
Arbor Biotechnologies’ “toolbox” approach to next-generation gene editing, its lead in vivo program ABO-101 for primary hyperoxaluria type 1 (PH1), and its CNS pipeline starting with ALS.
13 Nov 2026 · 32m · 13 chaptersHow to turn a BIO-Europe meeting into a lasting partnership
How to convert short, high-volume partnering meetings at major European conferences (Bio-Europe) into durable business relationships, emphasizing pre-event targeting, in-meeting efficiency, and…
6 Nov 2026 · 32m · 13 chaptersGenprex bets on a one-time gene therapy for diabetes (Part 3 of 3)
Genprex’s one-time AAV gene therapy GPX002 for diabetes, positioned as a potential “functional cure” that targets beta-cell restoration rather than GLP-1 symptom management.
30 Oct 2026 · 35m · 14 chaptersGLP-1 muscle loss: the next battleground in obesity treatment (Part 2 of 3)
GLP-1/incretin obesity drugs may cause meaningful muscle loss during rapid weight reduction, especially harming older adults with sarcopenia.
23 Oct 2026 · 28m · 13 chapters
The next big shake-up in the GLP-1 market? (Part 1 of 3)
Part 1 of a 3-part series on the “metabolic moment,” focusing on what’s next for the GLP-1 market as patents expire, generics arrive, delivery shifts from injections to oral, and big pharma…
16 Oct 2026 · 36m · 24 chaptersSaudi Arabia's biotech momentum: inside RGMBS 2026
The episode covers the Riyadh Global Medical Biotechnology Summit (RGMBS) 2026—its scale, dealmaking, scientific program, and how it supports Saudi Arabia’s biotech strategy (regional hub by 2030,…
9 Oct 2026 · 34m · 15 chaptersHow Flagship's Valo is reshaping AI drug discovery with human data
Flagship’s Valo (Velo) aims to improve AI-driven drug discovery by using “human causal biology” from real-world patient data (17+ million longitudinal records, up to ~20 years) plus predictive…
2 Oct 2026 · 36m · 10 chaptersTheialife’s race to bring a childhood myopia treatment to market
Thailife’s late-stage oral therapy (ND10/7-methylxanthine) aimed at preventing pediatric progressive myopia from progressing to high myopia, with FDA Phase 3 planning and a discussion of unmet need,…
25 Sep 2026 · 44m · 16 chaptersThe best biotech conversations you missed this summer
This summer-recap episode of Beyond Biotech (215) revisits seven conversations about getting therapies to the right place in the body and making novel mechanisms work in patients.
18 Sep 2026 · 40m · 13 chaptersRewriting the rules of genetic medicine with tRNA therapeutics
Alterna’s tRNA therapeutics platform aims to treat shared nonsense mutations across multiple rare diseases, rather than developing one gene-by-gene therapy per disease.
11 Sep 2026 · 31m · 16 chaptersHow Evox Therapeutics is targeting CNS diseases with exosomes
Evox Therapeutics’ approach to treating CNS diseases using engineered exosomes to deliver gene editing into the brain, aiming to bypass or avoid the blood-brain barrier.
4 Sep 2026 · 31m · 18 chaptersBIOSPAIN 2026: partnering, policy, and the rise of Spanish biotech
Episode 212 of Beyond Biotech spotlights BioSpain 2026 (Sept 29–Oct 1) in Bilbao, hosted by ASEBIO/Asabio and led by Stuart Medina of Acerbio.
28 Aug 2026 · 34m · 15 chaptersBeyond biology: Nanobiotix's physics-first approach to cancer
Nanobiotix’s “physics-based nanomedicine” for cancer, focusing on NBTXR3 (hafnium oxide nanoparticle radioenhancer) plus the NanoPrimer platform to improve delivery of genetic and other therapies.
21 Aug 2026 · 31m · 18 chaptersHow Cancer Research Horizons is building the future of childhood cancer medicines
How Cancer Research Horizons (Cancer Research UK’s innovation engine) turns early cancer science into treatments, diagnostics, and startups, and why it’s pushing “C-Further” to build childhood cancer…
14 Aug 2026 · 43m · 15 chaptersWhy Western pharma is sleeping on China's circular RNA revolution
Circular RNA therapeutics from China—why Western pharma is underinvesting—featuring Therona’s platform and clinical strategy, especially an in vivo CAR-T program.
7 Aug 2026 · 36m · 12 chaptersGain Therapeutics: a first-in-class, disease-modifying therapy for Parkinson's
Beyond Biotech episode 208 with Gene Mack of GAIN Therapeutics on GT02287, a first-in-class, disease-modifying allosteric small molecule therapy for Parkinson’s.
31 Jul 2026 · 42m · 17 chaptersWe use cookies.They keep VO running smoothly and help us improve it. Privacy policy